Skip to content

Risk factors for nocturnal hypertension including Sleep Apnea Syndromes (SAS) and diabetic autonomic neuropathy in patients with type 2 diabetes.

Risk factors for nocturnal hypertension including Sleep Apnea Syndromes (SAS) and diabetic autonomic neuropathy in patients with type 2 diabetes. - Risk factors for nocturnal hypertension in type 2 diabetes.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000013092
Enrollment
200
Registered
2014-02-06
Start date
2013-10-20
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes mellitus type 2 Hypertension

Interventions

None listed

Sponsors

Toranomon Hospital Department of Endocrinology and Metabolism.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Type 2 diabetic inpatients with hypertension. 2) Those who can understand the instruction and agree on the written consent.

Exclusion criteria

Exclusion criteria: 1) Patients with stroke. 2) Patients with heart failure. 3) Patients with chronic kidney disease(G4 or more severe). 4) Patients with dementia or depression. 5) Patients with CPAP treatment. 6) Patients with frequent PACs, PVCs or atrial fibrillation. 7) Patients with type 1 diabetes. 8) Patients with serious infection, inflammation, or injury, preoperative or postoperative state. 9) Heavy alcohol drinker (patients who drink more than 480 mL of Japanese Sake, 2L of beer, 180 mL of whisky, 360 mL of wine or 360 mL of Shochu per day). 10) Patients who are pregnant, hope to be pregnant, or are in lactation period. 11) Patients who are not applicable to this study judged by the medical doctor.

Design outcomes

Primary

MeasureTime frame
Diurnal variation in blood pressure, morning blood pressure surge.

Secondary

MeasureTime frame
Mean blood pressure, short-term blood pressure variability

Countries

Japan

Contacts

Public ContactAkihiro Nishimura MD

Toranomon Hospital Department of Endocrinology and Metabolism.

toranishi@gmail.com03-3588-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026